-
Study: PPIs shift NSAID stomach damage to small intestine; probiotics possible solution
HAMILTON, Ontario — Proton-pump inhibitors may aggravate, not soothe, stomach discomfort created through chronic use of nonsteroidal anti-inflammatory drugs for such conditions as arthritis, according to research released Thursday.
In a study published in the medical journal Gastroenterology, principal investigator John Wallace reported the extent of the hard-to-detect damage caused to the small intestine only recently has been discovered through use of small video cameras swallowed like pills.
-
Pfizer extends tender offer to acquire Icagen
NEW YORK — After entering a definitive agreement to acquire biopharmaceutical company Icagen, Pfizer has extended its tender offer for all outstanding shares of common stock.
Pfizer, which already has an 11% stake in Icagen, is offering the company a cash transaction of $6 per share. The tender offer, which was extended to Icagen through Pfizer's wholly owned subsidiary Eclipse Acquisition, expires at midnight on Sept. 1.
All other terms and conditions of the tender offer remain unchanged.